US$ 27.93
dr. tyna moore glp-1 EP. 172: Agonists and the Gut Microbiome: Unveiling Their Role in Metabolic Health Interview with Dr. Tyna Moore,
Description
Here's a breakdown of what we know so far: Type of Drug: Danuglipron belongs to a class of drugs called GLP-1 receptor agonists

Learn what researchers discovered, why the findings matter, and key reminders for people with type 2 diabetes concerned about brain health.
ALERT 1: Potential risk of suicidal thoughts The TGA has aligned product warnings for all GLP-1 RA medicines to ensure consistent []

Interview Courtesy | Ankit Kankar #GLP1 #Diabetes #Obesity #Cardiology #Metabolism #Therapeutics #Innovation #Healthcare #Medicine #Research #Pharmacology #Biotechnology #Clinicaltrials #Prevention #Wellness